Which patient will benefit most from a platelet inhibitor after a heart operation? The Department of Cardiology of Inselspital, Bern University Hospital, can answer this question with a new test, which has been published in "The Lancet".
Spending less time in hospital, having to take less medication after surgery – both are concerns shared by most patients. In a study published this month, the Department of Cardiology of Inselspital addressed this concern.
In accordance with the principle of weighing benefits and risks, upon which all medical treatments are based, it took an in-depth look at medicinal after-care from the patients’ perspective.
After surgery on the coronary arteries, patients routinely receive platelet-inhibiting drugs for approx. one year. This is intended to prevent heart attacks. These drugs, however, may cause bleeding complications in some patients. Until now, doctors have been unable to find out how high the risk of bleeding was for each person.
Personalised after-care thanks to a simple test
In a multicentric study under the direction of Prof. Marco Valgimigli, from the Department of Cardiology of Inselspital, cardiologists have now developed a simple five-part test: This identifies the individual bleeding risk based on the factors of age, kidney function, haemoglobin level, number of white platelets and previous spontaneous bleedings.
In the case of a high risk, the drugs are prescribed for only approx. three months – because this period of time the patient benefits from the protective effect against heart attack, but has no serious side-effects.
People without an increased risk of bleeding, on the other hand, can take the medicinal coronary prophylaxis for longer because, with good protection, they do not have to worry about bleedings.
Prof. Dr. med. Marco Valgimigli, Senior Physician, Department of Cardiology, Inselspital, Bern University Hospital, +41 31 632 47 14, email@example.com.
Monika Kugemann | Universitätsspital Bern
Genetic differences between strains of Epstein-Barr virus can alter its activity
18.07.2019 | University of Sussex
Machine learning platform guides pancreatic cyst management in patients
18.07.2019 | American Association for the Advancement of Science
Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.
Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.
Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
18.07.2019 | Health and Medicine
18.07.2019 | Life Sciences
18.07.2019 | Health and Medicine